Companies: 11,396     total market cap: โ‚น14019.211 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novartis
NVS
#47
Rank
โ‚น28.926 T
Marketcap
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Country
โ‚น15,316
Share price
-0.37%
Change (1 day)
35.81%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : โ‚น7.474 Trillion

According to Novartis's latest financial reports the company's total liabilities are โ‚น7.474 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novartis - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น4.428 T-7.78%
2022-12-31โ‚น4.801 T0.85%
2021-12-31โ‚น4.761 T-8.44%
2020-12-31โ‚น5.200 T16.1%
2019-12-31โ‚น4.479 T-4.19%
2018-12-31โ‚น4.675 T24.43%
2017-12-31โ‚น3.757 T0.12%
2016-12-31โ‚น3.753 T3.76%
2015-12-31โ‚น3.617 T4.65%
2014-12-31โ‚น3.456 T8.06%
2013-12-31โ‚น3.199 T6.37%
2012-12-31โ‚น3.007 T10.27%
2011-12-31โ‚น2.727 T13.66%
2010-12-31โ‚น2.399 T35.94%
2009-12-31โ‚น1.765 T31.81%
2008-12-31โ‚น1.339 T30.96%
2007-12-31โ‚น1.022 T-13.57%
2006-12-31โ‚น1.183 T7.02%
2005-12-31โ‚น1.105 T20.57%
2004-12-31โ‚น916.96 B7.14%
2003-12-31โ‚น855.87 B6.94%
2002-12-31โ‚น800.36 B12.48%
2001-12-31โ‚น711.56 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.884 T 45.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.860 T 45.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น5.421 T-27.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น6.377 T-14.68%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น8.247 T 10.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.139 T-17.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.148 T-17.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น6.644 T-11.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น3.014 T-59.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com